IRIS Institutional Research Information System - OPENBS Open Archive UniBS

RUSSO, ISABELLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.688
EU - Europa 3.049
AS - Asia 2.213
SA - Sud America 394
Continente sconosciuto - Info sul continente non disponibili 149
AF - Africa 62
OC - Oceania 8
Totale 9.563
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.603
PL - Polonia 1.568
CN - Cina 779
SG - Singapore 715
BR - Brasile 332
UA - Ucraina 317
IT - Italia 238
HK - Hong Kong 217
VN - Vietnam 208
FR - Francia 197
DE - Germania 192
FI - Finlandia 189
GB - Regno Unito 130
RU - Federazione Russa 75
TR - Turchia 58
BD - Bangladesh 54
IE - Irlanda 54
CA - Canada 50
IN - India 40
ID - Indonesia 28
AR - Argentina 20
ZA - Sudafrica 20
JP - Giappone 17
BE - Belgio 16
KR - Corea 16
MX - Messico 16
NL - Olanda 15
EC - Ecuador 13
ES - Italia 13
NG - Nigeria 10
PK - Pakistan 10
CO - Colombia 9
IQ - Iraq 9
AT - Austria 8
AU - Australia 8
MA - Marocco 8
KE - Kenya 7
OM - Oman 7
SE - Svezia 7
CZ - Repubblica Ceca 6
IR - Iran 6
JO - Giordania 6
PH - Filippine 6
PY - Paraguay 6
SA - Arabia Saudita 6
IL - Israele 5
TN - Tunisia 5
VE - Venezuela 5
BG - Bulgaria 4
EG - Egitto 4
ET - Etiopia 4
EU - Europa 4
PS - Palestinian Territory 4
TT - Trinidad e Tobago 4
CL - Cile 3
CR - Costa Rica 3
GR - Grecia 3
KZ - Kazakistan 3
LT - Lituania 3
NP - Nepal 3
PE - Perù 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
BB - Barbados 2
BY - Bielorussia 2
CH - Svizzera 2
DZ - Algeria 2
JM - Giamaica 2
KG - Kirghizistan 2
MY - Malesia 2
SV - El Salvador 2
TH - Thailandia 2
UY - Uruguay 2
AM - Armenia 1
AO - Angola 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
GT - Guatemala 1
HN - Honduras 1
HU - Ungheria 1
KH - Cambogia 1
LB - Libano 1
LC - Santa Lucia 1
LV - Lettonia 1
MD - Moldavia 1
MK - Macedonia 1
NI - Nicaragua 1
PA - Panama 1
RS - Serbia 1
SC - Seychelles 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SR - Suriname 1
TW - Taiwan 1
Totale 9.419
Salva come PNG Salva come JPEG
Città #
Warsaw 1.567
Singapore 404
Ashburn 345
Fairfield 308
Jacksonville 242
Hong Kong 216
Woodbridge 204
San Jose 192
Beijing 167
Helsinki 147
Seattle 139
The Dalles 132
Houston 130
Cambridge 127
Council Bluffs 118
Chandler 106
Princeton 105
New York 104
Wilmington 101
Ann Arbor 88
Nanjing 87
Brescia 80
Los Angeles 67
Lauterbourg 63
Ho Chi Minh City 55
Dong Ket 54
Dublin 54
Istanbul 49
Hanoi 45
Dallas 40
Dearborn 40
Moscow 39
Buffalo 38
Milan 35
Munich 34
Columbus 33
Changsha 32
São Paulo 30
Nanchang 28
Phoenix 27
Chicago 26
Des Moines 25
Shanghai 24
Orem 23
Hebei 22
Jakarta 22
Redondo Beach 22
Shenyang 22
San Francisco 21
Tianjin 20
Frankfurt am Main 19
Santa Clara 19
Toronto 18
Jiaxing 17
Jinan 17
Tokyo 17
Brussels 16
London 16
Turku 16
Guangzhou 15
Lappeenranta 15
Johannesburg 14
San Diego 14
Zhengzhou 14
Hangzhou 11
Kunming 11
Montreal 11
Poplar 11
Rio de Janeiro 11
Brooklyn 10
Curitiba 10
Nuremberg 10
Abuja 9
Atlanta 9
Brasília 9
Denver 9
Burlington 8
Chennai 8
Taizhou 8
Amsterdam 7
Belo Horizonte 7
Dhaka 7
Lancaster 7
Ningbo 7
Philadelphia 7
Salt Lake City 7
Taiyuan 7
Baltimore 6
Basingstoke 6
Boston 6
Fuzhou 6
Goiânia 6
Hefei 6
Mexico City 6
Miami 6
Nairobi 6
Stockholm 6
Turin 6
Amman 5
Augusta 5
Totale 6.603
Salva come PNG Salva come JPEG
Nome #
Effects of neuroinflammation on the regenerative capacity of brain stem cells 345
3,6'-Dithiothalidomide, a new TNF-α synthesis inhibitor, attenuates the effect of Aβ1-42 intracerebroventricular injection on hippocampal neurogenesis and memory deficit 328
Cyclooxygenase-1 is involved in the inhibition of hippocampal neurogenesis after lipopolysaccharide-induced neuroinflammation 283
LRRK2 kinase activity regulates synaptic vesicle trafficking and neurotransmitter release through modulation of LRRK2 macro-molecular complex 266
AMPA receptor regulation at the mRNA and protein level in rat primary cortical cultures 264
Molecular insights and functional implication of LRRK2 dimerization 258
Genetic and pharmacological evidence that G2019S LRRK2 confers a hyperkinetic phenotype, resistant to motor decline associated with aging 244
Cross-talk between LRRK2 and PKA: Implication for Parkinson's disease? 241
ADAR therapy: a breakthrough against genetic disorders 238
Age-dependent dopamine transporter dysfunction and Serine129 phospho-α-synuclein overload in G2019S LRRK2 mice 238
LRRK2 phosphorylates pre-synaptic N-ethylmaleimide sensitive fusion (NSF) protein enhancing its ATPase activity and SNARE complex disassembling rate 235
Leucine-rich repeat kinase 2 interacts with p21-activated kinase 6 to control neurite complexity in mammalian brain 227
Leucine-rich repeat kinase 2 positively regulates inflammation and down-regulates NF-κB p50 signaling in cultured microglia cells 227
LRRK2 and neuroinflammation: Partners in crime in Parkinson's disease? 217
Exosomes-associated neurodegeneration and progression of Parkinson's disease 206
AMPA receptor regulation at the mRNA and protein level in rat primary cortical cultures 203
AMPA RECEPTOR PROPERTIES ARE MODULATED IN THE EARLY STAGES FOLLOWING PILOCARPINE-INDUCED STATUS EPILEPTICUS 179
Leucine-Rich Repeat Kinase-2 Controls the Differentiation and Maturation of Oligodendrocytes in Mice and Zebrafish 167
Activation of neuronal differentiation in vivo and in vitro by means of synthetic peptide 143
α-Synuclein and Glia in Parkinson’s Disease: A Beneficial or a Detrimental Duet for the Endo-Lysosomal System? 142
The LRRK2 variant E193K prevents mitochondrial fission upon MPP+ treatment by altering LRRK2 binding to DRP1 141
Modulation of dendritic AMPA receptor mRNA trafficking by RNA splicing and editing 136
Modulation of dendritic AMPA receptor mRNA trafficking by RNA splicing and editing 136
Modulation of dendritic AMPA receptor mRNA trafficking by RNA splicing and editing 135
Exploring LRRK2-dependent clearance of α-synuclein pffs in glial cells via clusterin 133
EXPLORING LRRK2 BIOLOGY IN GLIAL CELLS: IMPLICATION FOR PARKINSON’S DISEASE 133
The role of LRRK2 on PKA-NFκB pathway in microglia cells: implications for Parkinson's disease 131
Extracellular clusterin limits the uptake of α-synuclein fibrils by murine and human astrocytes 131
Parkinson’s disease LRRK2 modulates microglia physiology in health and disease 130
Transcriptome analysis of LRRK2 knock-out microglia cells reveals alterations of inflammatory- and oxidative stress-related pathways upon treatment with α-synuclein fibrils. 126
LRRK2 phosphorylation on synapsin I regulates glutamate release at presynaptic sites. 121
In vitro and in vivo analysis of dendritic AMPA receptor mRNAs trafficking 117
Leucine-rich repeat kinase-2 controls protein kinase A activation state through phosphodiesterase 4 116
Tumor necrosis factor-α synthesis inhibitor 3,6'-dithiothalidomide attenuates markers of inflammation, Alzheimer pathology and behavioral deficits in animal models of neuroinflammation and Alzheimer's disease 116
In vitro and in vivo analysis of dendritic AMPA receptor mRNAs trafficking 113
3,6'-Dithiothalidomide, a TNF-α inhibitor, attenuates hippocampal neurogenesis and memory deficits in response to Aβ1-42 intracerebroventricular injection in mice 112
In vitro and in vivo analysis of dendritic AMPA receptor mRNAs trafficking 108
3,6'-Dithiothalidomide treatment attenuates neuroinflammation, memory deficits and hippocampal neurogenesis in response to Aβ1-42 intracerebroventricular injection in mice 100
Impact of COVID-19 on the oncological outcomes of colorectal cancer surgery in northern Italy in 2019 and 2020: multicentre comparative cohort study 99
In vitro and in vivo analysis of dendritic AMPA receptor mRNAs trafficking 99
LRRK2 interacts and phosphorylates Synapsin I: implication for synaptic vesicle trafficking 99
miRNome Profiling Detects miR-101-3p and miR-142-5p as Putative Blood Biomarkers of Frailty Syndrome 98
Genetic and pharmacological evidence that G2019S LRRK2 confers hyperkinetic phenotype and prevents motor decline associated with aging 95
LRRK2 is a positive modulator of neuroinflammation in microglia cells 95
Dopamine-Dependent Ketamine Modulation of Glutamatergic Synaptic Plasticity in the Prelimbic Cortex of Adult Rats Exposed to Acute Stress 95
LRRK2 Kinase Inhibition Attenuates Neuroinflammation and Cytotoxicity in Animal Models of Alzheimer's and Parkinson's Disease-Related Neuroinflammation 91
Leucine-rich repeat kinase-2 controls a-synuclein fibrils clearance in glial cells via clusterin 88
Changes at glutamate tripartite synapses in the prefrontal cortex of a new animal model of resilience/vulnerability to acute stress 88
In vitro Glutamate treatment modify AMPA RNA editing and ADARs activity 87
LRRK2 kinase activity modulates neuroinflammation in microglia cells 86
LRRK2 positively regulates inflammation and NF-kB p50 inhibitory signaling in microglia cells 86
Transcriptional Profiling of Rat Prefrontal Cortex after Acute Inescapable Footshock Stress 86
Functional and Molecular Changes in the Prefrontal Cortex of the Chronic Mild Stress Rat Model of Depression and Modulation by Acute Ketamine 85
The protein kinase LRRK2 is involved in neurotransmitter release by interacting and phosphorylating synapsin I in nerve terminals. 80
ADAR therapeutics to tackle neurodegenerative disorders 79
LRRK2 Kinase Inhibition Attenuates Astrocytic Activation in Response to Amyloid β1-42 Fibrils 77
LRRK2 kinase activity modulates neuroinflammation in microglia cells 77
LRRK2 phosphorylates pre-synaptic N-ethylmaleimide sensitive factor (NSF) enhancing its ATPase activity 77
Impact of Parkinson's disease related LRRK2 protein kinase activity at the pre-synaptic site 74
The Down-Regulation of Clusterin Expression Enhances the αSynuclein Aggregation Process 74
THE GROUP II P21-ACTIVATED KINASES AS THERAPAUTIC TARGETS IN LRRK2-RELATED PARKINSON'S DISEASE 72
The group II p21-activated kinases as therapautic targets in LRRK2-related Parkinson’s disease 71
LRRK2 as a target for modulating immune system responses 66
Functional impact of CYFIP2 RNA Editing on actin regulation, axon growth, and spinogenesis 64
RNA editing of CYFIP2 regulates in vitro neuronal development 57
ADAR therapeutics to tackle neurodegenerative disorders 55
Astrocytes carrying LRRK2 G2019S exhibit increased levels of clusterin chaperone via miR-22-5p and reduced ability to take up α-synuclein fibrils 54
Leucine-rich repeat kinase 2-related functions in GLIA: an update of the last years 46
LRRK2-Mediated Neuroinflammation-Induced Neuronal Dysfunctions in a Parkinson's and Alzheimer's Disease Cellular Model 45
Exploring the effect of LRRK2-mediated neuroinflammation on neuronal tau pathology: implications for Parkinson’s disease 43
Functional impact of CYFIP2 RNA editing on actin regulation, axon growth, and spinogenesis 41
Uncovering the Role of Natural and Synthetic Small Molecules in Counteracting the Burden of α-Synuclein Aggregates and Related Toxicity in Different Models of Parkinson's Disease 40
EXPLORING LRRK2-TAU INTERPLAY IN PARKINSON’S DISEASE 37
The Emerging Role of the Molecular Chaperone Clusterin in Parkinson’s Disease 32
Poly-γ-glutamic acid alleviates cytotoxicity and inflammation induced by pre-formed fibrils of α-synuclein in murine primary astrocytes 30
LRRK2 Mutation Alters Dopamine D2 Receptor Localization in Induced Pluripotent Stem Cells-Derived Astrocytes From Parkinson's Disease Patients: Implications for Neuronal Damage 9
Totale 9.563
Salva come PNG Salva come JPEG
Categoria #
all - tutte 39.416
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.416
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022315 0 0 6 11 3 10 25 30 23 57 42 108
2022/2023392 69 8 15 33 31 95 5 25 70 5 18 18
2023/2024455 21 20 38 73 16 56 15 13 117 4 16 66
2024/20251.013 3 7 20 147 117 106 96 22 58 80 237 120
2025/20262.914 293 355 218 425 315 219 420 130 146 252 89 52
2026/2027318 112 115 91 0 0 0 0 0 0 0 0 0
Totale 9.563